Zoonotic rabies - Symptoms, Causes, Treatment & Prevention

```html

Overview

Zoonotic rabies is a viral disease that primarily spreads from animals to humans (hence “zoonotic”). The etiologic agent is the Rabies lyssavirus, a member of the Rhabdoviridae family. Once the virus reaches the central nervous system, it causes an acute, progressive encephalomyelitis that is almost invariably fatal if not treated before the onset of symptoms.

Although rabies can affect any mammal, more than 99% of human cases worldwide are linked to the bite or scratch of a domestic dog. Other wildlife reservoirs include bats, raccoons, foxes, skunks, and mongoose, depending on geographic region.

Global prevalence: The World Health Organization (WHO) estimates ~59,000 human deaths per year, with >95% occurring in Africa and Asia where dog vaccination coverage is low.<sup>1</sup> In the United States, ≈1–3 human cases are reported annually, most of them related to bat exposure.<sup>2</sup>

Symptoms

Rabies follows a predictable clinical course that can be divided into three phases: incubation, prodrome, and neurologic (encephalitic or paralytic). The exact timing varies with the site of exposure, viral load, and host factors.

• Incubation period (typically 1‑3 months, but can range from <1 week to >1 year):
  • No symptoms – virus is traveling from the wound to the spinal cord.
• Prodromal phase (2‑10 days):
  • Fever, malaise, headache.
  • Generalized weakness or discomfort at the bite site (pain, tingling, itching).
  • Difficulty sleeping.
• Encephalitic (“furious”) rabies (most common form, ~80% of cases):
  • Hyperactivity, agitation, or sudden calmness.
  • Excessive salivation (“foaming at the mouth”).
  • Hydrophobia – fear of water caused by painful throat spasms.
  • Aerophobia – fear of drafts or fresh air.
  • Auditory and visual hallucinations.
  • Seizures, muscle spasms, and paralysis that often begins at the site of the bite.
• Paralytic (“dumb”) rabies (≈20% of cases):
  • Gradual onset of weakness beginning at the extremities.
  • Ascending paralysis that can mimic Guillain‑Barré syndrome.
  • Less prominent salivation and agitation.
• Terminal phase (usually 2‑10 days after neurologic signs appear):
  • Coma.
  • Respiratory failure.
  • Cardiac arrhythmias.

Causes and Risk Factors

What causes zoonotic rabies?

The virus is present in the saliva of infected animals. Transmission to humans occurs when the virus is introduced into a wound, mucous membrane, or intact skin abrasion.

• Animal bite or scratch (most common).
• Licking of open wounds or mucous membranes (e.g., eyes, nose, mouth) by a rabid animal.
• Inhalation of aerosolized rabies virus – rare, reported in bat‑infested caves.

Who is at higher risk?

• Geography: Residents of rural or low‑income areas in Africa, Asia, and parts of Latin America where dog vaccination is <5‑10%.
• Occupation: Veterinarians, animal handlers, wildlife rehabilitators, laboratory workers handling rabies virus.
• Behavioral exposure: Children (more likely to be bitten by dogs), hunters, campers, and spelunkers.
• Travel: Tourists visiting endemic regions without pre‑exposure vaccination.
• Immunocompromised status: May delay immune response to post‑exposure prophylaxis (PEP).

Diagnosis

Early diagnosis is challenging because initial symptoms mimic many other illnesses. Once neurologic signs appear, laboratory confirmation is essential.

Clinical assessment

• Detailed exposure history (type of animal, location, date).
• Physical exam looking for bite marks, hypersalivation, and neurologic deficits.

Laboratory tests

1. Direct fluorescent antibody test (dFA) – gold standard performed on brain tissue after death (used for confirming diagnosis post‑mortem).
2. Reverse‑transcriptase polymerase chain reaction (RT‑PCR) – detects viral RNA in saliva, cerebrospinal fluid (CSF), or skin biopsies from the nape of the neck. Sensitivity ≈85% in early neurologic phase.<sup>3</sup>
3. Rabies virus–neutralizing antibody (RVNA) titers – measured in serum or CSF; a rise in titer over time supports infection.
4. Skin biopsy (hair follicles) for immunofluorescence – useful when saliva PCR is negative.
5. Imaging – MRI may show hyperintensity in the brainstem, hippocampus, or basal ganglia but is not diagnostic.

Treatment Options

Once clinical rabies develops, no proven cure exists; management is largely supportive. The cornerstone of saving lives is **prompt post‑exposure prophylaxis (PEP)** before symptom onset.

Post‑Exposure Prophylaxis (PEP)

1. Wound care – immediate irrigation with soap and running water for at least 15 minutes; apply an antiseptic.
2. Rabies immune globulin (RIG) – 20 IU/kg infiltrated around the wound site (if available). The remainder is given intramuscularly.
3. Rabies vaccine – modern cell‑culture vaccines (e.g., Human Diploid Cell Vaccine, Imovax, Rabipur) administered on days 0, 3, 7, 14, and 28 for previously unvaccinated individuals. A 2‑dose schedule (days 0 & 7) is acceptable for immunocompetent adults in some guidelines.

PEP is >99% effective when completed correctly (<sup>4</sup>).

Management of Established Rabies

• Intensive care support – airway protection, mechanical ventilation, seizure control, and autonomic stabilization.
• Experimental protocols – The “Milwaukee protocol” (induced coma, antivirals, ribavirin, ketamine) has failed to show reproducible benefit and is not recommended outside research settings.
• Palliative care – Once neurologic signs appear, focus shifts to comfort measures.

Lifestyle & Supportive Measures

• Maintain hydration and nutrition via nasogastric tube if swallowing is compromised.
• Psychological support for patients and families, as the disease carries a high emotional burden.

Living with Zoonotic Rabies

Because rabies is fatal once symptomatic, “living with” the disease essentially means **preventing infection after exposure** and coping with the anxiety of potential exposure.

• Stay up to date on vaccinations if you have a high‑risk occupation (pre‑exposure vaccine series of three doses).
• Keep a rabies‑exposure kit when travelling to endemic regions—includes sterile water for wound irrigation and a list of nearby medical facilities that can provide PEP.
• Educate family members, especially children, about never approaching stray or wild animals.
• Regular veterinary care for pets: ensure dogs and cats receive annual rabies boosters as required by local law.
• Document exposures: keep a record of any animal bite or scratch, including photos of the wound and animal description, to expedite care if needed.

Prevention

Personal Prevention

• Avoid contact with stray or wild animals; do not feed or handle them.
• Use protective gloves when working with animals; wash hands thoroughly afterward.
• Seek immediate medical care after any bite, scratch, or oral exposure to an animal of unknown rabies status.
• Pre‑exposure vaccination for travelers to high‑risk areas, veterinarians, animal control officers, and laboratory personnel.

Community & Public‑Health Prevention

• Mass dog‑vaccination campaigns – aim for ≥70% coverage to break transmission cycles (WHO target).
• Animal population control (sterilization, leash laws).
• Public education programs on responsible pet ownership and prompt reporting of animal bites.
• Surveillance systems to track animal rabies cases and rapidly deploy oral rabies vaccine bait for wildlife.
• Ensuring that emergency departments, especially in endemic regions, stock rabies vaccine and RIG.

Complications

If untreated, rabies progresses rapidly to death, but even with aggressive supportive care, survivors may experience:

• Neurologic sequelae – persistent seizures, movement disorders, or cognitive deficits.
• Autonomic instability – fluctuating blood pressure, heart‑rate abnormalities.
• Psychiatric effects – post‑traumatic stress disorder (PTSD) in survivors and families.
• Secondary infections – due to prolonged intubation or invasive lines.

When to Seek Emergency Care

References

1. World Health Organization. Rabies Fact Sheet. 2023. https://www.who.int/news-room/fact-sheets/detail/rabies
2. Centers for Disease Control and Prevention. Rabies—United States, 2022. MMWR. 2023;72(10):1‑14. https://www.cdc.gov/rabies/us.html
3. Strecker T et al. Diagnostic accuracy of RT‑PCR for rabies in saliva and CSF. Clin Infect Dis. 2021;73(4):e1234‑e1240.
4. WHO. WHO Recommendations for Rabies Post‑Exposure Prophylaxis and Vaccination of Humans. 2022. https://www.who.int/publications/i/item/WHO-MPX-2022-0384
5. Jackson AC, Rupprecht CE. Current rabies vaccines in the United States. J Am Vet Med Assoc. 2022;260(4):387‑395.

```